Cell line name NCC-GCTB2-C1
Accession CVCL_A0SR
Resource Identification Initiative To cite this cell line use: NCC-GCTB2-C1 (RRID:CVCL_A0SR)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: 64 hours (PubMed=34304386).
Omics: SNP array analysis.
Derived from site: In situ; Bone, proximal tibia; UBERON=UBERON_0008772.
Sequence variations
Mutation; HGNC; 4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=34304386).
Disease Malignancy in giant cell tumor of bone (NCIt: C4304)
Giant cell tumor of bone (ORDO: Orphanet_363976)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 70Y
Category Cancer cell line
STR profile

Source(s): PubMed=34304386


Amelogenin X,Y
CSF1PO 11,12
D5S818 10,13
D7S820 11
D13S317 10
D16S539 11,13
D21S11 29,30
TH01 9
TPOX 8,11
vWA 14,19

PubMed=34304386; DOI=10.1007/s13577-021-00579-z
Yoshimatsu Y., Noguchi R., Tsuchiya R., Ono T., Sin Y., Akane S., Sugaya J., Mori T., Fukushima S., Yoshida A., Kawai A., Kondo T.
Establishment and characterization of novel patient-derived cell lines from giant cell tumor of bone.
Hum. Cell 34:1899-1910(2021)

Encyclopedic resources Wikidata; Q108821011

Additional information

Weight N/A
User Category

Academia/non-profit organization, For-profit organization


There are no reviews yet.

Be the first to review “NCC-GCTB2-C1”

Your email address will not be published. Required fields are marked *